Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2) (N-Term) Peptide
-
- Target See all LZTS2 products
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LZTS2 antibody (Catalog #: ARP58817_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
- Background
-
LZTS2 is a negative regulator of katanin-mediated microtubule severing and release from the centrosome. LZTS2 is required for central spindle formation and the completion of cytokinesis. LZTS2 may negatively regulate axonal outgrowth by preventing the for
Alias Symbols: KIAA1813, LAPSER1, RP11-108L7.8
Protein Interaction Partner: A2BP1,CCDC85B,GFI1B,NINL,PAK7,RBPMS,RHOXF2,TRAF2,TRIM29,ZNF581,CCDC85B,NINL,PAK7,RBPMS,RHOXF2,TRAF2,TRIM29,ZNF581
Protein Size: 669 - Molecular Weight
- 73 kDa
- Gene ID
- 84445
- NCBI Accession
- NM_032429, NP_115805
- UniProt
- Q9BRK4
-